Epidemiological Factors

Epidemiological factors mainly include age, gender, ethnicity, disease, medication, diet, exposure to the environment, smoking, sleep, etc.
The search result for the Risk factor Category "Epidemiological"
A total of 986 results found based on your keywords
RF_ID Disease Name Species RF_Name Association Condition PMID
308 Amyotrophic lateral sclerosis human 20% continuous increase of any agricultural land or specific crop type RF Total agricultural land 28851431
308 Amyotrophic lateral sclerosis human 20% continuous increase of any agricultural land or specific crop type RF Orchards 28851431
308 Amyotrophic lateral sclerosis human 20% continuous increase of any agricultural land or specific crop type RF Olive groves 28851431
309 Alzheimer's disease human 25(OH)D deficiency PF 28522216
310 Alzheimer's Disease human a decrease in LRP10 function RF 22734645
311 Amyotrophic Lateral Sclerosis human A high intake of carbohydrate RF 17852010
312 Alzheimer’s Disease human A priori occupations RF Printers, mechanics, garage workers, oilers, painters, auto body workers, wood finishers, shoemakers, and dry cleaners (as one of two longest held occupations). 7771442
313 Alzheimer’s Disease human Activities of daily living assistance RF after Hemodialysis Initiation 30093374
314 Tourette Syndrome human ADHD family history positive RF 20654033
315 Parkinson's Disease human Obesity RF 31019987
316 Tuberous sclerosis complex human administration of multiple antiepileptic drugs RF 20113608
317 Parkinson's Disease human Adult nutrient intake RF 10661654
318 Alzheimer's disease human African ancestry RF 28369008
319 Alzheimer's Disease human Age RF in females 26343475
319 Alzheimer's Disease human Age RF 22976076
319 Alzheimer’s Disease human Age RF 30103328
319 Alzheimer’s Disease human Age RF after Hemodialysis Initiation 30093374
319 Alzheimer’s Disease human Age RF after Hemodialysis Initiation 30093374
319 Alzheimer’s Disease human Age RF after Hemodialysis Initiation 30093374
319 Alzheimer’s Disease human Age RF after Hemodialysis Initiation 30093374
319 Alzheimer's Disease human Age RF 25624416
319 Alzheimer's Disease human Age RF 25401488
319 Alzheimer's Disease human Age RF 20016220
319 Alzheimer's disease human Age RF 31058682
319 Alzheimer's disease human Age RF 24489845
319 Alzheimer's disease human Age RF 22526079
319 Amyotrophic lateral sclerosis rat Age RF 30873018
319 Parkinson's Disease human Age PF GCH1 genotype T allele carries 27871051
319 Parkinson's Disease rhesus monkey Age RF 21587290
319 Parkinson's Disease human Age RF 17884509
319 Alzheimer's Disease human Age RF 28806610
319 Alzheimer's disease human Age RF people with mild cognitive impairment (MCI) 21518614
319 Alzheimer's disease human Age RF in patients after spine surgery 20375503
320 Amyotrophic Lateral Sclerosis human Age at cessation of smoking RF 16963407
321 Amyotrophic lateral sclerosis human Age at first trauma leading to functional disability RF <35 years 29063790
321 Amyotrophic lateral sclerosis human Age at first trauma leading to functional disability RF 35–54 years 29063790
321 Amyotrophic lateral sclerosis human Age at first trauma leading to functional disability RF 35–54 years 29063790
322 Motor Neuron Disease human Age at menarche RF Age at menarche: >=16 1745327
323 Motor Neuron Disease human Age at natural menopause RF Age at natural menopause: 45-49 1745327
323 Motor Neuron Disease human Age at natural menopause RF Age at natural menopause: <=44 1745327
324 Alzheimer’s Disease human age in first degree relatives RF age of 90 in first degree relatives 8411049
325 Tuberous sclerosis complex human age of onset RF 20113608
326 Amyotrophic lateral sclerosis human Age of sport activity onset PF 24706338
326 Amyotrophic lateral sclerosis human Age of sport activity onset PF Significant adjusted OR 24706338
326 Amyotrophic lateral sclerosis human Age of sport activity onset PF 24706338
327 Alzheimer's disease human age-associated decline in health status RF the nontraditional risk factors index [FI-NTRF] was constructed for predict Alzheimer disease and dementia 21753161
328 Amyotrophic Lateral Sclerosis human Agricultural chemicals RF 20012543
329 Amyotrophic lateral sclerosis human Agricultural chemicals (pesticides) RF 29681882
330 Amyotrophic Lateral Sclerosis human agricultural work RF 15995797
331 Amyotrophic lateral sclerosis human Air Force RF Adjusted for matching factors and socioeconomic status (SES) 26583610
332 Alzheimer's disease human Air pollution RF 30741678
332 Amyotrophic lateral sclerosis human Air pollution RF the nitrogen oxides NO2 and NOx 29483062
332 Amyotrophic Lateral Sclerosis human Air pollution RF Air Pollution Exposure( NOx concentrations) 29989551
332 Amyotrophic Lateral Sclerosis human Air pollution RF Air Pollution Exposure(NO2) 29989551
332 Amyotrophic Lateral Sclerosis human Air pollution RF Air Pollution Exposure(PM2.5) 29989551
333 Frontotemporal Dementia human alcohol consumption PF 28946566
333 Frontotemporal Dementia human alcohol consumption PF in current alcohol consumers 28946566
334 Alzheimer’s Disease human Alcohol dependence PF after Hemodialysis Initiation 30093374
335 Amyotrophic lateral sclerosis human Amateur sport activity PF 24706338
336 Alzheimer’s Disease human amnestic mild cognitive impairment (aMCI) RF 30199883
337 Alzheimer's Disease human an increase in K(+) intake PF 26391254
338 Amyotrophic lateral sclerosis human an IQR increase of CO RF 30622072
339 Amyotrophic lateral sclerosis human an IQR increase of PM10 RF 30622072
340 Amyotrophic lateral sclerosis human an IQR increase of PM2.5 RF 30622072
341 Amyotrophic lateral sclerosis human an IQR increase of SO2 RF 30622072
342 Alzheimer's disease human anemia RF 24419041
343 Alzheimer’s Disease human Anxiety RF Calculated by fixed effect model 30339108
343 Alzheimer’s Disease human Anxiety RF Calculated by random effect model 30339108
343 Alzheimer's Disease human Anxiety RF Model 1: Main effect unadjusted 29077487
343 Alzheimer's Disease human Anxiety RF Model 2: Main effects adjusted for sex, education, age, and race. 29077487
343 Alzheimer's Disease human Anxiety RF Model 3: Main effects adjusted for adjusted for sex, age, education, race, e4 carrier status 29077487
343 Alzheimer's Disease human Anxiety RF Model 4: Main effects adjusted for adjusted for sex, age, education, race, e4 carrier status, the presence of hypertension and hypercholesterolemia 29077487
343 Alzheimer's disease human anxiety RF people with mild cognitive impairment (MCI) 21518614
343 Parkinson's Disease human Anxiety RF 12784267
343 Alzheimer's disease human Anxiety RF Clinically significant anxiety,not subclinical anxiety 30825716
344 Amyotrophic lateral sclerosis human Military work RF Adjusted for matching factors and socioeconomic status (SES) 26583610
345 Lewy body dementia human Arterial hypertension (AH) RF 20965516
346 Alzheimer’s Disease human Arthritis PF 2146525
346 Amyotrophic lateral sclerosis human Arthritis PF 27065942
347 Alzheimer’s Disease human Atherosclerotic heart disease PF after Hemodialysis Initiation 30093374
348 Alzheimer's Disease human atrial fibrillation (AF) RF 24825565
349 Tuberous sclerosis complex human autistic features RF 28721058
350 Amyotrophic lateral sclerosis human Average daily adulthood PA(Physical Activity) RF 26998882
351 Amyotrophic lateral sclerosis human Average daily PA(Physical Activity) in last 5–15 years RF 26998882
352 Amyotrophic lateral sclerosis human AVM(arteriovenous malformation) RF all 26260352
352 Amyotrophic lateral sclerosis human AVM(arteriovenous malformation) RF cerebral vessels 26260352
353 Amyotrophic lateral sclerosis human Bank tellers RF worked or were unemployed at 1991 Italian census, and were still resident in Turin at the beginning of 1996 28201634
354 Alzheimer's Disease human beliefs about stress RF 28605999
355 Alzheimer’s Disease human Benzene, toluene exposure RF 7771442
356 progressive supranuclear palsy human beta-blocker use RF 31420308
357 Alzheimer's disease human Better sleep consolidation attenuate PF in APOE e4 carriers 24145819
358 Alzheimer's disease human Bilingualism PF 30475769
359 Amyotrophic lateral sclerosis human blood levels of Copper (μg/dL) RF Adjusted for age, gender and race/ethnicity. 27085208
360 Amyotrophic lateral sclerosis human blood levels of Manganese (μg/dL) RF Adjusted for age, gender and race/ethnicity. 27085208
361 Amyotrophic lateral sclerosis human blood levels of Selenium (μg/dL) PF Adjusted for age, gender and race/ethnicity. 27085208
361 Amyotrophic lateral sclerosis human blood levels of Selenium (μg/dL) PF Adjusted for age, gender and race/ethnicity. 27085208
361 Amyotrophic lateral sclerosis human blood levels of Selenium (μg/dL) PF Adjusted for age, gender and race/ethnicity. 27085208
361 Amyotrophic lateral sclerosis human blood levels of Selenium (μg/dL) PF Adjusted for age, gender and race/ethnicity. 27085208
362 Amyotrophic lateral sclerosis human blood levels of Zinc (μg/dL) PF Adjusted for age, gender and race/ethnicity. 27085208
362 Amyotrophic lateral sclerosis human blood levels of Zinc (μg/dL) PF Adjusted for age, gender and race/ethnicity. 27085208
363 Alzheimer's Disease human blood pressure variability (BPV) RF 28784823
364 Amyotrophic lateral sclerosis human BMI history RF OR controlled for age, sex, duration of school education, and smoking status 28975435
364 Amyotrophic lateral sclerosis human BMI history RF OR controlled for age, sex, duration of school education, and smoking status 28975435
364 Amyotrophic lateral sclerosis human BMI history RF OR controlled for age, sex, duration of school education, and smoking status 28975435
364 Amyotrophic lateral sclerosis human BMI history PF OR controlled for age, sex, duration of school education, and smoking status 28975435
365 Amyotrophic lateral sclerosis human BMI(Body Mass Index) RF Low BMI(Body Mass Index) 31155341
366 Amyotrophic lateral sclerosis human Boat, sail, or kayak RF residents of New England or the bordering New York region at the time of enrollment 28122372
367 Alzheimer’s Disease human Body mass index RF after Hemodialysis Initiation; <18.5 30093374
367 Alzheimer’s Disease human Body mass index RF after Hemodialysis Initiation; 18.5–25.0 30093374
367 Alzheimer’s Disease human Body mass index RF after Hemodialysis Initiation; 25.0–30.0 30093374
367 Alzheimer’s Disease human Body mass index RF extrinsic epigenetic age acceleration 30167451
367 Alzheimer’s Disease human Body mass index RF intrinsic epigenetic age acceleration 30167451
368 Alzheimer's disease human bone mineral density (BMD) RF low bone mineral density (BMD) 21187587
369 Alzheimer's disease rabbit Caffeine PF even very low doses of caffeine might protect against sporadic AD 20638472
369 Alzheimer's disease human Caffeine PF coffee drinking of 3-5 cups per day at midlife was associated with a decreased risk of dementia/AD by about 65% at late-life 20182054
370 Parkinson's Disease human caffeine intake RF GRIN2A rs4998386 T allele;taking creatine who also have high levels of caffeine intake 28320167
371 Tuberous sclerosis complex human calcification in the cerebral parenchyma RF 29929111
372 Alzheimer’s Disease human Cancer PF after Hemodialysis Initiation 30093374
372 Alzheimer's disease human Cancer PF 30906403
372 Alzheimer's disease human Cancer PF Cancer History(Cancer survivors) 28035936
373 Alzheimer's disease human Cardiorespiratory fitness (CRF) PF 28293467
374 Alzheimer’s Disease human cardiovascular disease (CaVD) RF 30149459
375 Alzheimer's Disease human carotid atherosclerosis RF 28810593
376 Alzheimer’s Disease human Cataract PF 2146525
377 Alzheimer’s Disease human cerebrovascular disease RF Cerebrovascular Alterations 30355253
377 Alzheimer's Disease human cerebrovascular disease RF 28806610
378 Alzheimer's disease human characteristics of anxiety RF people with mild cognitive impairment (MCI) 21518614
379 Alzheimer’s Disease human childhood stress RF 30020441
379 Alzheimer’s Disease human childhood stress RF adjusted for age, education, income and other covariates 30020441
380 Parkinson's Disease human chronic exposure to metals RF 9065542
381 Alzheimer's disease mice Chronic low-dose-rate ionising radiation RF chronic low-dose-rate radiation exposure (1 mGy/day or 20 mGy/day) 27708245
382 Tourette Syndrome human chronic maternal anxiety RF mothers' chronic maternal anxiety affecting the offspring 26174227
383 Alzheimer's Disease human chronic periodontitis (CP) RF 10-year CP exposure 28784164
384 Parkinson's Disease human chronic renal dysfunction RF Older adults 31021467
385 Alzheimer's disease mice Chronic Sleep Deprivation(SD) RF 26757041
386 Parkinson's Disease rat cinnarizine(a calcium antagonist that produces human parkinsonism) RF (a calcium antagonist that produces human parkinsonism) 15993444
387 Amyotrophic lateral sclerosis mouse Circadian rhythm dysfunction (CRD) RF Transgenic mice overexpressing human SOD1 were obtained from the Nanjing Biomedical Research Institute of Nanjing University 29740382
387 Parkinson's Disease rat Circadian rhythm dysfunction (CRD) RF 27046648
388 Alzheimer's Disease human coffee consumption RF per one cup a day 29212772
389 Alzheimer's Disease human cognitive impairment RF 23254639
390 Alzheimer’s Disease human Congestive heart failure PF after Hemodialysis Initiation 30093374
391 Alzheimer’s Disease human constipation RF colorectal cancer and AD have similar epidemiologic feature 30323761
391 Parkinson's Disease human Constipation RF the relative risk was higher for men than for women 27234704
391 Parkinson's Disease human Constipation RF 27444575
392 Amyotrophic lateral sclerosis human construction work RF 27124833
392 Amyotrophic Lateral Sclerosis human construction work RF 19750102
393 Amyotrophic lateral sclerosis human COPD(chronic obstructive pulmonary disease) PF 27065942
394 Lewy body dementia human Cortical thinning RF patients with idiopathic REM sleep behavior disorder (iRBD) 31069252
395 Alzheimer's disease human covariant associated with social status RF 26893902
396 Tourette Syndrome human culture level of parents RF lower culture level of parents 20654033
397 Amyotrophic lateral sclerosis human current proximity to any agricultural land or specific crop type within 100m from residence RF Total agricultural land 28851431
398 Amyotrophic lateral sclerosis human Defense NEC(Not Elsewhere Classified) RF Adjusted for matching factors and socioeconomic status (SES) 26583610
399 Creutzfeldt-Jakob disease human Dementia in family RF 3066847
400 Alzheimer's Disease human Depression RF clinically significant depressive symptoms at baseline 26343475
400 Alzheimer’s Disease human Depression RF 29606955
400 Alzheimer’s Disease human Depression RF fundamental shift in depression-related monoaminergic systems (including serotonin and noradrenaline) 29685068
400 Alzheimer's Disease human depression RF 28731429
400 Alzheimer's Disease human Depression RF 25401488
400 Alzheimer's Disease human depression RF 18603262
400 Lewy body dementia human depression RF 30503177
400 Parkinson's Disease human Depression RF 25995056
400 Parkinson's Disease human Depression RF 24089392
400 Alzheimer's Disease human Depression RF clinician verified;Model 1: Main effect unadjusted 29077487
400 Alzheimer's Disease human Depression RF clinician verified;Model 2: Main effects adjusted for sex, education, age, and race. 29077487
400 Alzheimer's Disease human Depression RF clinician verified;Model 3: Main effects adjusted for adjusted for sex, age, education, race, e4 carrier status 29077487
400 Alzheimer's Disease human Depression RF clinician verified;Model 4: Main effects adjusted for adjusted for sex, age, education, race, e4 carrier status, the presence of hypertension and hypercholesterolemia 29077487
400 Alzheimer's Disease human Depression RF Model 1: Main effect unadjusted 29077487
400 Alzheimer's Disease human Depression RF Model 2: Main effects adjusted for sex, education, age, and race. 29077487
400 Alzheimer's Disease human Depression RF Model 3: Main effects adjusted for adjusted for sex, age, education, race, e4 carrier status 29077487
400 Alzheimer's Disease human Depression RF Model 4: Main effects adjusted for adjusted for sex, age, education, race, e4 carrier status, the presence of hypertension and hypercholesterolemia 29077487
400 Alzheimer’s Disease human Depression RF Depressive disorder in last 10 years 2146525
400 Alzheimer's Disease human Depression RF 28605999
400 Alzheimer's disease human Depression RF HAM:Hamilton Depression Rating Scale 18327871
400 Alzheimer's disease mice Depression RF 27837334
400 Alzheimer's Disease human Depression RF Late-onset MD(major episode) with DEDS;after adjustment by age, gender, marital status, education, cognitive impairment, executive function and stroke history 22588687
400 Alzheimer's Disease human Depression RF Late-onset MDDIS(minor depressive disorders) with DEDS;after adjustment by age, gender, marital status, education, cognitive impairment, executive function and stroke history 22588687
400 Alzheimer's Disease human Depression RF late-onset MD with DEDS 22588687
400 Alzheimer's Disease human Depression RF late-onset MDDIS with DEDS 22588687
400 Alzheimer's Disease human Depression RF unadjusted 28560728
400 Alzheimer's Disease human Depression RF adjusteda without ε4 carrier status Hazard ratio 28560728
400 Alzheimer's Disease human Depression RF adjusted with ε4 carrier status Hazard ratio 28560728
400 Alzheimer's Disease human Depression RF personal history of depression 24596166
400 Parkinson's Disease human Depression RF Previous history of depression 21059511
400 Alzheimer's Disease human Depression RF recent depression last 2 years;unadjusted 28560728
400 Alzheimer's Disease human Depression RF recent depression last 2 years;adjusteda without ε4 carrier status Hazard ratio 28560728
400 Alzheimer's Disease human Depression RF recent depression last 2 years;adjusted with ε4 carrier status Hazard ratio 28560728
400 Alzheimer's Disease human Depression RF recent depression last 2 years;adjusted with ε4 carrier status and AD Medication use Hazard ratio 28560728
400 Alzheimer's Disease human Depression RF Model 1: Main effect unadjusted 29077487
400 Alzheimer's Disease human Depression RF Model 2: Main effects adjusted for sex, education, age, and race. 29077487
400 Alzheimer's Disease human Depression RF Model 3: Main effects adjusted for adjusted for sex, age, education, race, e4 carrier status 29077487
400 Alzheimer's Disease human Depression RF Model 4: Main effects adjusted for adjusted for sex, age, education, race, e4 carrier status, the presence of hypertension and hypercholesterolemia 29077487
400 Alzheimer's Disease human Depression RF Severe depression 23791538
401 Alzheimer’s Disease human Diabetes RF 29971140
401 Alzheimer’s Disease human Diabetes RF 30103328
401 Alzheimer’s Disease human Diabetes RF after Hemodialysis Initiation 30093374
401 Alzheimer's Disease human diabetes RF 28806610
401 Alzheimer's disease human Diabetes RF 28503814
401 Alzheimer's disease human diabetes RF people with mild cognitive impairment (MCI) 21518614
401 Alzheimer's disease human Diabetes PF with APOE4 genotype in AD population 18189240
401 Amyotrophic lateral sclerosis human Diabetes PF Unadjusted 26030836
401 Amyotrophic lateral sclerosis human Diabetes PF Adjusted for socioeconomic status, prior chronic obstructive pulmonary disease, marital status, and residence at amyotrophic lateral sclerosis diagnosis. 26030836
401 Amyotrophic lateral sclerosis human Diabetes PF Adjusted for socioeconomic status, prior chronic obstructive pulmonary disease, marital status, and residence at amyotrophic lateral sclerosis diagnosis, with diabetes and obesity simultaneously included in the model. 26030836
401 Parkinson's Disease human Diabetes RF 19467671
401 Parkinson's Disease human Diabetes RF 19467671
401 Parkinson's Disease human Diabetes RF 24955210
401 Alzheimer’s Disease human Diabetes RF 30149459
401 Alzheimer’s Disease human Diabetes RF 29606955
401 Alzheimer’s Disease human Diabetes RF 7473847
401 Alzheimer’s Disease human Diabetes RF 15148141
401 Alzheimer's Disease human Diabetes RF 26495049
401 Frontotemporal Dementia human Diabetes RF 24995127
401 Lewy body dementia human Diabetes RF 29971140
401 Alzheimer's disease human Diabetes RF 24489845
401 Alzheimer's disease human Diabetes RF people with mild memory impairment/no dementia (MMI/ND) 21205364
402 Alzheimer's Disease human dieldrin RF 22904031
403 Alzheimer's Disease human Dietary AGEs(dietary advanced glycation end products) RF 25633677
404 Amyotrophic Lateral Sclerosis human Dietary habits:Cold cuts RF all cases 19922125
404 Amyotrophic Lateral Sclerosis human Dietary habits:Cold cuts RF Bulbar cases 19922125
405 Creutzfeldt-Jakob disease human Dietary Risk RF Hot Dogs 24977122
405 Creutzfeldt-Jakob disease human Dietary Risk RF Sausage 24977122
405 Creutzfeldt-Jakob disease human Dietary Risk RF Pepperoni 24977122
405 Creutzfeldt-Jakob disease human Dietary Risk RF Kielbasa 24977122
405 Creutzfeldt-Jakob disease human Dietary Risk RF “Other” Canned Meat 24977122
405 Creutzfeldt-Jakob disease human Dietary Risk RF kidneys,ever 19144172
405 Creutzfeldt-Jakob disease human Dietary Risk RF consumption of raw meat 9660576
405 Creutzfeldt-Jakob disease human Dietary Risk RF consumption of brain 9660576
405 Alzheimer’s Disease human Dietary Risk PF Dietary sources that contain high amounts of DHA in phospholipid form 30289748
406 Alzheimer's disease mice dietary sugar or sucrose RF controlling the consumption of sugar-sweetened beverages may be an effective way to curtail the risk of developing AD 17942401
407 Parkinson's Disease human Dietary Vitamin E PF 30863359
408 Parkinson's Disease human dipstick-positive proteinuria RF Older adults 31021467
409 Alzheimer’s Disease human Disorders in a 1st-degree relative RF Dementia 2146525
409 Alzheimer’s Disease human Disorders in a 1st-degree relative RF Probable AD 2146525
409 Alzheimer’s Disease human Disorders in a 1st-degree relative RF Down’s syndrome 2146525
409 Alzheimer’s Disease human Disorders in a 1st-degree relative PF Thyroid disorders 2146525
410 Alzheimer’s Disease human Dispersion and Disengaged Lifestyle RF 31162439
411 Alzheimer's disease human disseminated mycoses RF 24452965
412 Amyotrophic lateral sclerosis human Distance agricultural areas RF 100m300m 29852480
413 Alzheimer's disease human dread fullness RF people with mild cognitive impairment (MCI) 21518614
414 Alzheimer's disease human Drinking RF Daily drinking 21187587
414 Alzheimer’s Disease human Drinking PF 12707449
414 Amyotrophic lateral sclerosis human Drinking RF 31155341
414 Amyotrophic lateral sclerosis human Drinking PF 22791740
414 Creutzfeldt-Jakob disease human Drinking PF Current alcohol 3066847
414 Frontotemporal Lobar Degeneration human Drinking PF 28946566
414 Frontotemporal Lobar Degeneration human Drinking PF Current alcohol consumers 28946566
415 Parkinson's Disease human Drug-induced parkinsonism RF 9703296
415 Parkinson's Disease human Drug-induced parkinsonism RF 9703296
416 Creutzfeldt-Jakob disease human Duration (years) lived or worked on farm or market garden RF 10-19 years 10073510
416 Creutzfeldt-Jakob disease human Duration (years) lived or worked on farm or market garden RF >=20 years 10073510
417 Frontotemporal Lobar Degeneration human duration of exposure PF for every 5 years of exposure increase 28946566
418 Parkinson's Disease human duration of exposure to levodopa RF 23836370
418 Parkinson's Disease human duration of exposure to levodopa RF 23836370
419 Amyotrophic lateral sclerosis human Duration of OCP(oral contraceptive) use (per year) PF female 28835399
420 Amyotrophic lateral sclerosis human Duration of physical activity PF 24706338
420 Amyotrophic lateral sclerosis human Duration of physical activity PF Significant adjusted OR 24706338
420 Amyotrophic lateral sclerosis human Duration of physical activity PF 24706338
420 Amyotrophic lateral sclerosis human Duration of physical activity PF 24706338
420 Amyotrophic lateral sclerosis human Duration of physical activity PF 24706338
421 Amyotrophic lateral sclerosis human Duration of sport activity PF 24706338
421 Amyotrophic lateral sclerosis human Duration of sport activity PF Significant adjusted OR 24706338
421 Amyotrophic lateral sclerosis human Duration of sport activity PF 24706338
421 Amyotrophic lateral sclerosis human Duration of sport activity PF 24706338
422 Alzheimer's disease human dyslipidemia RF 30894904
423 Creutzfeldt-Jakob disease human Ear piercing RF females only 12196646
424 Tuberous sclerosis complex human Early-onset and severe epilepsy RF in the first 2 years of life 31538337
425 Alzheimer's Disease human education PF a higher number of school years 25624416
425 Alzheimer's Disease human education PF 20016220
425 Alzheimer's disease human education RF 31058682
425 Multiple System Atrophy human education RF ≤ 12 years 18307243
425 Multiple System Atrophy human education RF ≤ 12 years;In Paris 18307243
425 Multiple System Atrophy human education RF ≤ 12 years;In another French region 18307243
425 progressive supranuclear palsy human education PF 29973911
425 Amyotrophic lateral sclerosis human education PF Exposure in the last 30 years 24979055
425 Amyotrophic lateral sclerosis human education PF Exposure in the last 10 years 24979055
425 Amyotrophic lateral sclerosis human education PF Exposure in the period from 30 years ago to 10 years ago 24979055
425 Amyotrophic lateral sclerosis human education PF Continuous Exposure in the last 30 years 24979055
425 progressive supranuclear palsy human education PF 31420308
425 progressive supranuclear palsy human education PF in the multi-variate analysis 31420308
425 Alzheimer's disease human education PF in PSEN1 E280A mutation carriers 26902171
425 Amyotrophic Lateral Sclerosis human education RF Elementary school（Crude OR） 17923612
425 Amyotrophic lateral sclerosis human education PF Exposure Ever Happened in Entire Occupational History 27159543
425 Amyotrophic lateral sclerosis human education PF Exposure Ever Happened in Last 10 years 27159543
425 Amyotrophic lateral sclerosis human education PF Exposure Ever Happened 10-30 years Ago 27159543
425 Amyotrophic lateral sclerosis human education PF Exposure Ever Happened >30 years Ago 27159543
425 Alzheimer's disease human education PF people with mild cognitive impairment (MCI) 21518614
425 Amyotrophic Lateral Sclerosis human education RF 31011473
425 Alzheimer's Disease human education PF per year of education completed 29212772
425 Alzheimer's Disease human education PF per unit higher log odds of having completed college/university 29212772
425 Amyotrophic lateral sclerosis human education PF Longer duration of education 31155341
425 Tourette Syndrome human education RF low family education 20654033
425 Tourette Syndrome human education RF low level of parental education 22738448
425 Alzheimer's disease human education RF lower education 18446027
425 Alzheimer's disease human education RF Lower levels of education 30425786
425 Lewy body dementia human education RF fewer than 5 years of formal education 27264344
425 Alzheimer's Disease human education RF Lack of formal education 25401488
425 Alzheimer's Disease human education RF Low Education 26495049
425 Alzheimer’s Disease human education RF Low educational attainent 29606955
426 Amyotrophic lateral sclerosis human Electric current injuries RF 27124833
426 Amyotrophic lateral sclerosis human Electric current injuries RF 29681882
427 Alzheimer’s Disease human Employment status PF after Hemodialysis Initiation; Employed 30093374
427 Alzheimer’s Disease human Employment status RF after Hemodialysis Initiation; Other 30093374
428 Alzheimer's Disease human endothelial dysfunction RF specifically loss of endothelial NO 23745722
429 Alzheimer's disease human environmental exposure to cadmium RF high cadmium levels (>0.6 μg/L) 27301955
430 Amyotrophic lateral sclerosis human Environmental toxins RF organochlorine pesticides (OCPs), polychlorinated biphenyls (PCBs) and brominated flame retardants (BFRs) 27231185
431 Tuberous sclerosis complex human epilepsy RF 26631248
432 Amyotrophic lateral sclerosis human Ever worked in US Armed Forces RF Exposure Ever Happened 10-30 years Ago 27159543
433 Alzheimer's disease mice excess zinc exposure RF 21179415
434 Parkinson's Disease human exercise PF 12140099
434 Parkinson's Disease human exercise PF 12140099
435 Alzheimer's Disease human experienced appreciable weight loss RF 18835864
436 Chronic Traumatic Encephalopathy human Exposure to contact sports RF 26518018
437 Parkinson's Disease human exposure to hydrocarbon solvents RF 10980731
438 Amyotrophic lateral sclerosis human Exposure to Lead RF residents of New England or the bordering New York region at the time of enrollment 28122372
438 Amyotrophic lateral sclerosis human Exposure to Lead RF residents of New England or the bordering New York region at the time of enrollment 28122372
438 Alzheimer's Disease human Exposure to Lead RF Cigarette smoking 29089568
438 Amyotrophic Lateral Sclerosis human Exposure to Lead RF 19750102
438 Amyotrophic Lateral Sclerosis human Exposure to Lead RF Ever had a job with lead exposure 16909025
438 Amyotrophic Lateral Sclerosis human Exposure to Lead RF Lifetime days of lead exposure:2,000+ 16909025
439 Parkinson's Disease human exposure to metals RF high reported industrial release of copper or manganese 20959505
439 Parkinson's Disease human exposure to metals RF high reported industrial release of copper or manganese 20959505
440 Alzheimer’s Disease human Exposure to N2O RF 29991368
441 Parkinson's Disease human Exposure to neuroleptic drugs RF 10047927
442 progressive supranuclear palsy human exposure to organic solvents RF self-reporting exposure to organic solvents 26854325
443 Parkinson's Disease human exposure to Pb RF 17185278
444 Amyotrophic lateral sclerosis human Exposure to Pesticide RF residents of New England or the bordering New York region at the time of enrollment 28122372
444 Amyotrophic lateral sclerosis human Exposure to Pesticide RF residents of New England or the bordering New York region at the time of enrollment 28122372
444 Parkinson's Disease human Exposure to Pesticide RF 11437458
444 Amyotrophic Lateral Sclerosis human Exposure to Pesticide RF In a conditional logistic regression model 20847462
444 Parkinson's Disease human Exposure to Pesticide RF 21059511
444 Parkinson's Disease rat Exposure to Pesticide RF 22563483
444 progressive supranuclear palsy human Exposure to Pesticide RF self-reporting exposure to pesticides 26854325
445 Alzheimer’s Disease human Exposure to PM2.5 RF 29935448
446 Amyotrophic lateral sclerosis human Exposure to Solvents RF residents of New England or the bordering New York region at the time of enrollment 28122372
447 Amyotrophic lateral sclerosis human Exposure to the highest quartiles of PM10 RF 30622072
448 Amyotrophic lateral sclerosis human Exposure to the highest quartiles of PM2.5 RF 30622072
449 Parkinson's Disease human exposure to trichloroethylene (TCE) RF 22083847
450 Amyotrophic lateral sclerosis human Exposure to welding or soldering materials RF 27124833
451 Parkinson's Disease human well water ingestion RF 1584237
452 Frontotemporal Lobar Degeneration human Familial aggregation RF first-degree relatives (parents and siblings) of frontotemporal dementia (FTD) patients 9633692
453 Tourette Syndrome human family conflict RF 22738448
453 Tourette Syndrome human family conflict RF 20654033
454 Tourette Syndrome human family control and fetal anoxia RF 22738448
455 Tourette Syndrome human family history RF 22738448
456 Alzheimer's Disease human family history of cardiovascular diseases RF 24596166
457 Lewy body dementia human Family history of dementia RF 16801670
458 Alzheimer's disease human Family history of dementia (FH) RF 26531229
459 Alzheimer's disease human family history of dementia (within third-degree relatives) RF people with mild memory impairment/no dementia (MMI/ND) 21205364
460 Alzheimer's disease human farming PF 31239120
460 Alzheimer's disease human farming PF 31239120
460 Parkinson's Disease human farming RF 11437458
460 Multiple System Atrophy human farming RF 1-20 years 27670212
460 Multiple System Atrophy human farming RF 1-20 years 27670212
460 Multiple System Atrophy human farming RF >20 years 27670212
460 Multiple System Atrophy human farming RF >20 years 27670212
460 Multiple System Atrophy human farming RF MSA cases vs. hospital controls 15382209
460 Multiple System Atrophy human farming RF MSA cases vs. hospital controls 15382209
460 Multiple System Atrophy human farming RF MSA cases vs. population controls 15382209
460 Multiple System Atrophy human farming RF MSA cases vs. population controls 15382209
460 Multiple System Atrophy human farming RF MSA cases vs. population controls;>20 years 15382209
460 Multiple System Atrophy human farming RF MSA cases vs. population controls;>20 years 15382209
315 Alzheimer's Disease human Obesity RF being obese (BMI ≥30) at age 30, 40, or 45 years and jointly centrally obese (waist circumference ≥80th percentile) at age 30, 35, or 50 years 18835864
315 Parkinson's Disease human Obesity RF 24955210
461 Tourette Syndrome human Febrile convulsions(FC) RF 24907027
462 Creutzfeldt-Jakob disease human Ferret contact RF 3066847
463 Amyotrophic Lateral Sclerosis human Fire fighting occupations RF 20698805
463 Amyotrophic Lateral Sclerosis human Fire fighting occupations RF 20698805
464 Tourette Syndrome human first-degree relatives RF 26083307
464 Frontotemporal Dementia human first-degree relatives RF First-degree relatives(parents) 9633692
465 Alzheimer's Disease human Formaldehyde (FA) RF 24766729
466 Amyotrophic lateral sclerosis human Fractures RF all 28316249
466 Amyotrophic lateral sclerosis human Fractures RF osteoporotic 28316249
466 Amyotrophic lateral sclerosis human Fractures RF non-osteoporotic 28316249
466 Amyotrophic lateral sclerosis human Fractures RF traumatic 28316249
466 Amyotrophic lateral sclerosis human Fractures RF non-traumatic 28316249
467 Creutzfeldt-Jakob disease human Frequent exposure RF frequent exposure to leather products 9660576
467 Creutzfeldt-Jakob disease human Frequent exposure RF exposure to fertiliser consisting of hoofs and horns 9660576
468 Amyotrophic lateral sclerosis human Fungal infection RF 25892962
469 Alzheimer's Disease human Gender RF 28806610
469 Alzheimer's Disease human Gender RF 25624416
469 Alzheimer's Disease human Gender RF 20016220
469 Alzheimer's disease human Gender RF 27105335
469 Alzheimer's disease human Gender RF 24489845
469 Alzheimer's disease human Gender RF 22526079
469 Alzheimer’s Disease human Gender RF after Hemodialysis Initiation 30093374
469 Amyotrophic lateral sclerosis human Gender PF 27065942
469 Parkinson's Disease human gender RF 20111594
470 Amyotrophic lateral sclerosis human General practitioners RF worked or were unemployed at 1991 Italian census, and were still resident in Turin at the beginning of 1996 28201634
471 Parkinson's Disease human glyphosate exposure RF 30799335
472 progressive supranuclear palsy human have worked in transportation RF 26854325
473 Alzheimer's disease human Having a first-degree relative or a parent with dementia RF 26531229
474 Amyotrophic Lateral Sclerosis human having a past history of CS/SSM RF 17538776
475 Amyotrophic Lateral Sclerosis human having surgical treatment for CS/SSM RF 17538776
476 Lewy body dementia human Having three metabolic risk factors RF 29971140
477 Alzheimer’s Disease human head circumference (HC) RF within the lowest quintile of HC for women 9222166
478 Amyotrophic Lateral Sclerosis human Head injury RF all cases 19922125
478 Amyotrophic Lateral Sclerosis human Head injury RF Bulbar cases 19922125
478 Amyotrophic Lateral Sclerosis human head injury RF Age at last injury (years)≥29 20129626
478 Amyotrophic Lateral Sclerosis human head injury RF Years between last injury and reference date <=24 years 20129626
478 Amyotrophic Lateral Sclerosis human head injury RF Years between last injury and reference date <=15 years 20129626
478 Alzheimer’s Disease human Head injury RF 10746604
478 Alzheimer’s Disease human Head injury RF 12707449
478 Alzheimer’s Disease human Head injury RF 12707449
478 Parkinson's Disease human head injury RF early in life 25603768
478 Parkinson's Disease human head injury RF 12140099
478 Amyotrophic lateral sclerosis human head injury RF 31155341
478 Amyotrophic lateral sclerosis human head injury RF 2+ Trauma 29063790
478 Amyotrophic lateral sclerosis human head injury RF 25059395
478 Frontotemporal Dementia human head injury RF 14617722
478 Parkinson's Disease human head injury RF 28748275
478 Amyotrophic lateral sclerosis human head injury RF Head trauma leading to functional disability 29063790
479 Alzheimer's disease human Healthy diet PF in late life 22163237
480 Frontotemporal Dementia human heart disease PF 22465176
480 Frontotemporal Lobar Degeneration human heart disease PF 22465176
481 Amyotrophic Lateral Sclerosis human heavy metals RF 6538286
482 Amyotrophic lateral sclerosis human Heavy metals (lead) RF 29681882
483 Alzheimer's disease Heavy metals toxicity:Cadmium (Cd) RF 24557150
484 Parkinson's Disease human Hepatitis C virus(HCV) RF 26701382
484 Parkinson's Disease human Hepatitis C virus(HCV) RF 25608223
484 Parkinson's Disease human Hepatitis C virus(HCV) RF 30710864
485 Multiple System Atrophy human Herbal medications RF 20623770
485 Multiple System Atrophy human Herbal medications RF 20623770
486 Amyotrophic Lateral Sclerosis human Herbicides/Pesticides RF with the total SALS group 16946624
486 Amyotrophic Lateral Sclerosis human Herbicides/Pesticides RF with male SALS patients 16946624
487 Creutzfeldt-Jakob disease human hGH(human cadaver-sourced growth hormone) treatment RF 30045957
487 Creutzfeldt-Jakob disease human hGH(human cadaver-sourced growth hormone) treatment RF Proportion of doses risk category 1 (batches 1, 2, 3, 4, 7, 21, 26) 30045957
487 Creutzfeldt-Jakob disease human hGH(human cadaver-sourced growth hormone) treatment RF Proportion of doses risk category 2 (batches 10, 12, 13, 18, 24) 30045957
487 Creutzfeldt-Jakob disease human hGH(human cadaver-sourced growth hormone) treatment RF Proportion of doses risk category 3 (batches 5, 6, 8, 9, 11, 14, 15, 16, 17, 19, 20, 22, 23, 25, 27) 30045957
488 Alzheimer’s Disease human High blood pressure RF intrinsic epigenetic age acceleration 30167451
489 Alzheimer's Disease human High consumption of aluminum RF 19064650
490 progressive supranuclear palsy human high exposure to highly stressful events RF 28409749
491 Alzheimer's disease human High occupational attainment RF mild cognitive impairment(MCI) patient 27662289
491 Alzheimer's disease human High occupational attainment PF 27662289
492 Tuberous sclerosis complex human high tuber burden RF 28721058
493 Alzheimer's disease human higher age among senior citizens in urban communities RF 31286894
494 Alzheimer's Disease human higher body mass index RF 24596166
495 Alzheimer's Disease human higher CDR-SB scores RF in male 26343475
496 Alzheimer's disease human Higher leptin level PF 21187587
497 Alzheimer's Disease human higher levels of estrogen exposure RF 24968011
498 Alzheimer's Disease human higher levels of prenatal testosterone exposure RF 24968011
499 progressive supranuclear palsy human higher number of years of drinking well water RF 26854325
500 Alzheimer's disease human history of depressive episodes RF 18446027
501 Tuberous sclerosis complex human history of infantile spasm (epileptic spasms) RF 28721058
502 Creutzfeldt-Jakob disease human human growth hormone extract RF received human growth hormone extract for various period of time (mean +/- SD, 2.9 years) 8797466
503 Alzheimer's disease human Hypercholesterolemia RF 27921357
503 Amyotrophic lateral sclerosis human Hypercholesterolemia PF 25059395
504 Alzheimer's Disease human hyperhomocysteinemia RF 24656904
504 Alzheimer's disease human Hyperhomocysteinemia RF 23833960
505 Alzheimer's disease human hyperlipidemia RF people with mild cognitive impairment (MCI) 21518614
505 Alzheimer’s Disease human hyperlipidemia RF 29971140
505 Alzheimer's Disease human hyperlipidemia RF 28806610
505 Amyotrophic lateral sclerosis human Hyperlipidemia PF 27065942
505 Amyotrophic lateral sclerosis human Hyperlipidemia RF 30723964
505 Lewy body dementia human Hyperlipidemia RF 29971140
506 Alzheimer's Disease human hypertension RF 25624416
506 Amyotrophic lateral sclerosis human Hypertension PF 31155341
506 Alzheimer’s Disease human hypertension RF 29971140
506 Alzheimer’s Disease human hypertension RF 30149459
506 Alzheimer’s Disease human Hypertension RF after Hemodialysis Initiation 30093374
506 Alzheimer’s Disease human hypertension RF 7473847
506 Alzheimer's Disease human hypertension RF 20016220
506 Alzheimer's disease human hypertension RF 30894904
506 Alzheimer's disease human hypertension RF 24489845
506 Alzheimer's disease human hypertension RF people with mild cognitive impairment (MCI) 21518614
506 Amyotrophic lateral sclerosis human Hypertension PF 27065942
506 Lewy body dementia human hypertension RF 29971140
506 progressive supranuclear palsy human hypertension RF 31420308
506 progressive supranuclear palsy human hypertension RF in the multi-variate analysis 31420308
506 Parkinson's Disease human Hypertension RF 9778597
506 Alzheimer’s Disease human hypertension RF 29606955
506 Alzheimer's Disease human hypertension RF 26495049
507 Alzheimer’s Disease human hypertension and diabetes RF 29971140
508 Alzheimer’s Disease human hypertension and hyperlipidemia RF 29971140
509 Alzheimer’s Disease human hypertension, diabetes and hyperlipidemia RF 29971140
510 Alzheimer's disease human hypertensive RF 18288934
511 Parkinson's Disease human Idiopathic rapid eye movement sleep behaviour disorde RF 19843648
512 Alzheimer’s Disease human Illiteracy RF < 1 year at school 12212789
512 Alzheimer's Disease human Illiteracy RF 25401488
513 Amyotrophic lateral sclerosis human Immunosuppressive drugs PF 25059395
514 Alzheimer's disease human Improving cardiovascular functions PF mean velocity of the BA 28505975
514 Alzheimer's disease human Improving cardiovascular functions PF mean velocity of the LTICA 28505975
514 Alzheimer's disease human Improving cardiovascular functions PF Ejection fraction 28505975
515 Alzheimer’s Disease human Inability to ambulate RF after Hemodialysis Initiation 30093374
516 Amyotrophic lateral sclerosis human industrial chemicals RF residents of New England or the bordering New York region at the time of enrollment 28122372
516 Amyotrophic lateral sclerosis human industrial chemicals RF residents of New England or the bordering New York region at the time of enrollment 28122372
517 Amyotrophic lateral sclerosis human Industry in accommodation or food services PF Exposure Ever Happened in Entire Occupational History 27159543
517 Amyotrophic lateral sclerosis human Industry in accommodation or food services PF Exposure Ever Happened >30 years Ago 27159543
518 Amyotrophic lateral sclerosis human Industry in health care or social assistance PF Exposure Ever Happened in Entire Occupational History 27159543
519 Amyotrophic lateral sclerosis human Industry in ublic administration PF Exposure Ever Happened in Entire Occupational History 27159543
519 Amyotrophic lateral sclerosis human Industry in ublic administration PF Exposure Ever Happened 10-30 years Ago 27159543
520 Tuberous sclerosis complex human infantile spams RF 26631248
521 Parkinson's Disease human infection RF 30632012
522 Alzheimer's Disease human infectious burden:C. pneumoniae RF 24910016
523 Alzheimer's Disease human infectious burden:cytomegalovirus (CMV) RF 24910016
524 Amyotrophic Lateral Sclerosis human inhalation of BMAA, DAB, and other aerosolized cyanotoxins RF 19929742
525 Alzheimer’s Disease human institutionalization RF after Hemodialysis Initiation 30093374
526 Alzheimer's Disease human Insulin resistance (IR) RF 20031276
526 Alzheimer's disease human insulin resistance (IR) RF 27079723
527 Alzheimer's disease human intellectual work PF people with mild cognitive impairment (MCI) 21518614
528 Alzheimer's disease human introvert characteristics RF people with mild cognitive impairment (MCI) 21518614
529 Alzheimer's Disease human ionizing radiation RF 28671130
530 Alzheimer’s Disease human Job description only RF Exposure to printing/printer's ink, coal tar/creosote, oils, glues/resins/waxes, rubber production, or paints. 7771442
531 Alzheimer’s Disease human Jobs as seamstress, dressmaker and tailor RF 7677130
531 Alzheimer’s Disease human Jobs as seamstress, dressmaker and tailor RF 7677130
532 Amyotrophic lateral sclerosis human Jobs as workers or farmers RF 31155341
533 Creutzfeldt-Jakob disease human Keeping cats RF 3066847
534 Alzheimer’s Disease human Ketones exposure RF 7771442
535 Alzheimer's disease human lack of sports RF people with mild cognitive impairment (MCI) 21518614
536 Amyotrophic lateral sclerosis human Leisure time activity RF 23418211
537 Amyotrophic Lateral Sclerosis human Level of Herbicide/Pesticide Exposure RF the total SALS group 16946624
537 Amyotrophic Lateral Sclerosis human Level of Herbicide/Pesticide Exposure RF male SALS patients 16946624
538 Amyotrophic Lateral Sclerosis human Lifestyle factors RF Vigorous physical activity 19342254
538 Amyotrophic Lateral Sclerosis human Lifestyle factors RF self reported stress:high 19342254
538 Amyotrophic Lateral Sclerosis human Lifestyle factors RF Behavior pattern:Type A 19342254
538 Amyotrophic Lateral Sclerosis human Lifestyle factors RF Intake of green-yellow vegetables:Less 19342254
538 Amyotrophic Lateral Sclerosis human Lifestyle factors RF combination Type A behavior and Intake of green-yellow vegetables 19342254
539 Amyotrophic lateral sclerosis human Lifetime endogenous estrogen exposure (per year) RF 28835399
540 Alzheimer's Disease human light-moderate alcohol drinker RF 28806610
541 Amyotrophic Lateral Sclerosis human Living in rural environment RF Region of living more than 5 years before disease onset 31011473
542 progressive supranuclear palsy human living on a farm or ranch RF more years living on a farm or ranch 26854325
543 Alzheimer's disease human loneliness RF people with mild cognitive impairment (MCI) 21518614
544 Tourette Syndrome human longer delay of treatment RF 20654033
545 Alzheimer’s Disease human low education/rural residence RF 10636132
546 Alzheimer’s Disease human Malaria RF 2146525
547 Motor Neuron Disease human manual occupation RF 8229031
548 Amyotrophic Lateral Sclerosis human Market-oriented skilled agricultural workers RF 20012543
549 Tourette Syndrome human Maternal addiction disorders RF 28335873
550 Tourette Syndrome human Maternal affective disorders RF 28335873
551 Tourette Syndrome human Maternal anxiety disorders RF 28335873
552 Alzheimer's disease human Maternal breastfeeding history PF Women who breastfed had lower AD risk than women who did not breastfeed(p = 0.017) 23948914
553 Tourette Syndrome human Maternal personality disorders RF 28335873
554 Tourette Syndrome human maternal psychiatric diagnosis RF 28335873
555 Tourette Syndrome human Maternal psychotic disorders RF 28335873
556 Tourette Syndrome human Maternal toxic exposures RF Alcohol use in last 2 months of pregnancy; Mutually adjusted for other variables in the model, maternal age and socioeconomic status level. 24262815
556 Tourette Syndrome human Maternal toxic exposures RF Cannabis use in last 2 months of pregnancy; Mutually adjusted for other variables in the model, maternal age and socioeconomic status level. 24262815
557 Alzheimer’s Disease mice maternal transmission RF Tg2576 female mice 29691440
558 Motor Neuron Disease human Mechanical injuries RF Site: Column 1745327
558 Motor Neuron Disease human Mechanical injuries RF Site: Upper limbs 1745327
558 Motor Neuron Disease human Mechanical injuries RF Site: Lower limbs 1745327
558 Motor Neuron Disease human Mechanical injuries RF Site: Trunk 1745327
558 Motor Neuron Disease human Mechanical injuries RF All sites 1745327
559 Amyotrophic lateral sclerosis human medical service work RF 27124833
560 Amyotrophic lateral sclerosis human metals as Al, Cd, Hg, Mn and Pb RF 26671079
344 Amyotrophic lateral sclerosis human Military work RF born between 1945 and 1985 26468494
561 Amyotrophic lateral sclerosis human Moderate trauma RF 29063790
562 Alzheimer’s Disease human monozygotic(MZ) twins RF twins born in Finland before 1958 with both co-twins alive in 1967 8596319
563 progressive supranuclear palsy human more years living within one mile of an agricultural area RF more years living within one mile of an agricultural area 26854325
564 Parkinson's Disease human motor neuron disease (MND) RF 20669307
565 Tuberous sclerosis complex human mutations in TSC2 RF 26631248
566 Alzheimer's disease human Native American ancestry PF 28369008
567 Amyotrophic lateral sclerosis human Neurological PF 27065942
568 Alzheimer's disease human no chronic use of nonsteroidal anti-inflammatory drugs PF 18446027
569 Amyotrophic lateral sclerosis human Non Vigorous Physical Activities RF 28413696
570 Parkinson's Disease human non‐apnea sleep disorders (NSD) RF 28470725
571 Parkinson's Disease human non-hydroxychloroquine immunosuppressant therapy PF Sj?gren syndrome (SS) 30946325
572 Alzheimer's Disease human Nonmarried RF 25401488
573 Alzheimer's disease human nonstroke cardiovascular disease (CVD) RF in carriers of the ApoE4 allele 20473139
574 Alzheimer's disease human normal tension glaucoma (NTG) RF Among patients with NTG, none of the glaucoma eye drops used significantly changed the risk of subsequent AD. 30397009
575 Motor Neuron Disease human number of children RF number of children:3 1745327
576 Creutzfeldt-Jakob disease human Number of surgical procedures RF 1 time 12196646
576 Creutzfeldt-Jakob disease human Number of surgical procedures RF 2 times 12196646
576 Creutzfeldt-Jakob disease human Number of surgical procedures RF >=3 times 12196646
577 Amyotrophic lateral sclerosis human O2?tension RF low O2?tension 30863976
315 Alzheimer’s Disease human Obesity RF 29606955
315 Alzheimer's Disease human Obesity RF 26495049
315 Alzheimer's Disease human Obesity RF 26324099
315 Alzheimer's disease Obesity RF 31191220
315 Alzheimer's disease human obesity RF 30792733
315 Amyotrophic lateral sclerosis human Obesity PF Unadjusted 26030836
315 Amyotrophic lateral sclerosis human Obesity RF 27065942
315 Frontotemporal Dementia human obesity RF 30792733
315 Frontotemporal Lobar Degeneration human Obesity RF 30792733
315 Motor Neuron Disease human Obesity PF BMI>=30 22559076
578 Motor Neuron Disease human Occupation RF Work as farmers and breeders 1745327
578 Amyotrophic Lateral Sclerosis human Occupation RF Craft and related trades workers(Crude OR) 17923612
578 Amyotrophic Lateral Sclerosis human Occupation RF primary industrial occupations(at disease onset) 17538776
578 Amyotrophic Lateral Sclerosis human Occupation RF secondary industrial occupations(at disease onset) 17538776
578 Amyotrophic Lateral Sclerosis human Occupation PF tertiary industrial occupations(at disease onset) 17538776
578 Amyotrophic lateral sclerosis human Occupation RF Occupations in contact with customer;sworked or were unemployed at 1991 Italian census, and were still resident in Turin at the beginning of 1996 28201634
578 Amyotrophic lateral sclerosis human Occupation RF Primary occupation involves industrial chemicals;residents of New England or the bordering New York region at the time of enrollment 28122372
578 Amyotrophic lateral sclerosis human Occupation RF Primary occupation involves industrial chemicals;residents of New England or the bordering New York region at the time of enrollment 28122372
579 Creutzfeldt-Jakob disease human Occupational Exposure RF occupational exposure to animal laboratory 19144172
579 Motor Neuron Disease human Occupational Exposure RF occupational exposure to lead 8229031
579 Motor Neuron Disease human Occupational Exposure RF occupational exposure to solvents/chemicals 8229031
579 Amyotrophic lateral sclerosis human Occupational Exposure PF Occupational exposure to lead;Exposure Ever Happened in Entire Occupational History 27159543
579 Amyotrophic lateral sclerosis human Occupational Exposure RF Occupational exposure to pesticide;Exposure in the last 30 years 24979055
579 Amyotrophic lateral sclerosis human Occupational Exposure RF Occupational exposure to pesticide;Exposure Ever Happened in Entire Occupational History 27159543
579 Amyotrophic lateral sclerosis human Occupational Exposure RF Occupational exposure to pesticide;Exposure Ever Happened in Last 10 years 27159543
579 Amyotrophic lateral sclerosis human Occupational Exposure RF Occupational exposure to pesticide;Exposure Ever Happened 10-30 years Ago 27159543
579 progressive supranuclear palsy human Occupational Exposure RF occupational metal exposure 26854325
580 Amyotrophic Lateral Sclerosis human Occupational history RF Occupational history:Building and construction sector of economic activity;Spinal cases 19922125
580 Amyotrophic Lateral Sclerosis human Occupational history RF Occupational history:Exposure to building and construction materials;Spinal cases 19922125
580 Amyotrophic Lateral Sclerosis human Occupational history RF Occupational history:Exposure to metals and metal fumes;Spinal cases 19922125
581 Amyotrophic lateral sclerosis human OCP(oral contraceptive) PF female 28835399
582 Amyotrophic lateral sclerosis human office work RF 27124833
583 Alzheimer's disease human often taking part in recreational activities PF people with mild cognitive impairment (MCI) 21518614
584 Alzheimer's Disease human okra RF particularly in people carrying a H63D polymorphism 26170247
585 Amyotrophic lateral sclerosis human Organic solvents RF 29681882
586 Amyotrophic lateral sclerosis human Organized sport activity PF 24706338
586 Amyotrophic lateral sclerosis human Organized sport activity PF Significant adjusted OR 24706338
587 Parkinson's Disease human organophosphate (OP) or carbamate (CM) poisoning RF 27781262
588 Alzheimer’s Disease human Other solvents exposure RF 7771442
589 Amyotrophic lateral sclerosis human overall muscle strength RF Low overall muscle strength 29285652
590 Amyotrophic Lateral Sclerosis human pack-years RF Bulbar cases 19922125
591 Parkinson's Disease human paraquat exposure RF 23150532
592 Alzheimer's disease human Parental death during childhood RF with strength of these associations attenuated by remarriage of the widowed parent. 21873837
593 Amyotrophic lateral sclerosis human particulate matter RF PM2.5, PM10, and PMcoarse 29483062
594 Amyotrophic lateral sclerosis human particulate matter absorption RF PM2.5absorption 29483062
595 Tourette Syndrome human Paternal anxiety disorders RF 28335873
596 Tourette Syndrome human Paternal OCD RF 28335873
597 Tourette Syndrome human paternal psychiatric diagnosis RF 28335873
598 Parkinson's Disease rat Peripheral inflammation RF 20584104
599 Alzheimer’s Disease human Peripheral vascular disease PF after Hemodialysis Initiation 30093374
600 Alzheimer's Disease human personal experience with AD RF 28605999
601 Creutzfeldt-Jakob disease human Pets RF other than cats/dogs 3066847
602 Alzheimer’s Disease human Phenols, alcohols exposure RF 7771442
603 Alzheimer's disease human phosphatidylinositol clathrin assembly lymphoid-myeloid leukemia (PICALM) RF 24067654
604 Amyotrophic lateral sclerosis human Physical activity PF 24706338
604 Amyotrophic lateral sclerosis human Physical activity PF Significant adjusted OR 24706338
605 Alzheimer’s Disease human Physical inactivity RF 29606955
605 Alzheimer's Disease human Physical Inactivity RF 26495049
606 Alzheimer’s Disease human Physically underactive RF 2146525
606 Alzheimer’s Disease human Physically underactive RF 2146525
607 Multiple System Atrophy human plant and machine operators and assemblers RF 18307243
607 Multiple System Atrophy human plant and machine operators and assemblers RF ≤ 11 years 18307243
607 Multiple System Atrophy human plant and machine operators and assemblers RF ≥ 11years 18307243
608 Parkinson's Disease human Plant Extract PF 24955210
609 Amyotrophic Lateral Sclerosis human playing professional football RF >5 years 15634730
610 Parkinson's Disease human Polychlorinated biphenyls (PCBs)exposure RF greater susceptibility of females. 22906799
610 Parkinson's Disease human Polychlorinated biphenyls (PCBs)exposure RF greater susceptibility of females. 22906799
611 Tuberous sclerosis complex human poor control of subsequent seizures after IS RF 16043792
612 Amyotrophic Lateral Sclerosis human precision metal workers RF 19750102
613 Alzheimer’s Disease human pregnancy RF pregnant 5xFAD transgenic mice 29855361
614 Tourette Syndrome human Pregnancy complications RF Less than adequate weight gain; Mutually adjusted for other variables in the model, maternal age and socioeconomic status level. 24262815
615 Alzheimer's Disease human prenatal estrogen exposure RF lower levels of prenatal estrogen exposure 24968011
616 Tourette Syndrome human pre-natal maternal depression RF mothers' pre-natal maternal depression affecting the offspring 26174227
617 Tourette Syndrome human Prenatal maternal smoking RF Prenatal maternal smoking affecting the offspring 25796373
618 Alzheimer's Disease human prenatal testosterone exposure RF lower levels of prenatal testosterone exposure 24968011
619 Parkinson's Disease human pretreatment motor dysfunction RF especially among older patients 9447497
620 Parkinson's Disease human Prior stroke RF 31019987
621 Alzheimer’s Disease human Probable solvent exposure RF Any above-named solvent or "job description." 7771442
621 Alzheimer’s Disease human Probable solvent exposure RF Any above-named solvent or "job description." 7771442
622 Amyotrophic lateral sclerosis human Professional sports RF 29681882
623 Tuberous sclerosis complex human prolonged duration of IS RF per 1-month interval 16043792
624 Tuberous sclerosis complex human prolonged time from treatment initiation until the cessation of IS RF 16043792
625 Alzheimer's disease human Proton pump inhibitors (PPIs) RF Chronic consumption of PPIs 20456731
626 Parkinson's Disease human psychiatric disorder RF particularly in people under age 50 18080857
627 Creutzfeldt-Jakob disease human Psychiatric visit RF 12196646
628 Alzheimer’s Disease human Race RF after Hemodialysis Initiation 30093374
628 Alzheimer’s Disease human Race RF after Hemodialysis Initiation 30093374
628 Amyotrophic lateral sclerosis human Race RF AA 27065942
628 Amyotrophic lateral sclerosis human Race PF other 27065942
629 Amyotrophic lateral sclerosis human Reading PF 31155341
629 Alzheimer's Disease human Reading RF reading occasionally 28806610
629 Alzheimer's disease human Reading PF people with mild cognitive impairment (MCI) 21518614
630 Alzheimer's disease human regular "mind-body" religious meditative activities(or kowtow) PF 26757186
631 Creutzfeldt-Jakob disease human regular GP visits RF 19144172
632 Creutzfeldt-Jakob disease human regular medication RF 19144172
633 Chronic Traumatic Encephalopathy mice Repeated mild traumatic brain injury (r-mTBI) RF APOE3 and APOE4 specific effects following injury in a mouse model of r-mTBI 30711612
634 Creutzfeldt-Jakob disease human Residence or employment RF Live or employed in farms 10073510
635 Amyotrophic lateral sclerosis human Retirement or unemployment PF 31155341
636 Parkinson's Disease human Rosacea constitutes RF 26999031
637 Parkinson's Disease human Rural living RF 21059511
637 Parkinson's Disease human Rural living RF 11437458
637 Parkinson's Disease human Rural living RF 11437458
637 Parkinson's Disease human Rural living RF 9778597
638 Alzheimer's Disease human Rural residency RF 25401488
639 Amyotrophic lateral sclerosis human SAH(subarachnoid haemorrhage) RF Transient ischaemic attack 26260352
640 Amyotrophic lateral sclerosis human Sales representatives RF worked or were unemployed at 1991 Italian census, and were still resident in Turin at the beginning of 1996 28201634
641 Tourette Syndrome human second-degree relatives RF 26083307
642 Tuberous sclerosis complex human Seizure type (ie, infantile spasms) RF 9520012
643 Amyotrophic Lateral Sclerosis human selenium overexposure RF 21215776
644 Alzheimer's Disease human serum cholesterol RF 22904031
645 Tuberous sclerosis complex human severe mental retardation RF 28721058
646 Alzheimer's Disease human severe OSA(obstructive sleep apnea) RF ≥30 vs. <5 apnea-hypopnea events/hour;using adjudicated outcomes 28738188
647 Amyotrophic lateral sclerosis human Severe physical activities PF 31155341
648 Alzheimer's Disease human severe PWMH RF in male 26343475
649 Parkinson's Disease human Sj?gren syndrome (SS) RF 30946325
650 Alzheimer's Disease human Sleep disturbance RF Model 1: Main effect unadjusted 29077487
650 Alzheimer's Disease human Sleep disturbance RF Model 2: Main effects adjusted for sex, education, age, and race. 29077487
650 Alzheimer's Disease human Sleep disturbance RF Model 3: Main effects adjusted for adjusted for sex, age, education, race, e4 carrier status 29077487
650 Alzheimer's Disease human Sleep disturbance RF Model 4: Main effects adjusted for adjusted for sex, age, education, race, e4 carrier status, the presence of hypertension and hypercholesterolemia 29077487
651 Alzheimer's disease Sleep-wake regulation RF 30649520
652 Alzheimer's disease human Smoking RF Current smokers 21187587
652 Amyotrophic Lateral Sclerosis human Smoking RF current smokers 22791740
652 Alzheimer's Disease human Smoking RF current smoking 28806610
652 Alzheimer's Disease human Smoking RF in Mongolian males aged over 55 years 25657695
652 Multiple System Atrophy human Smoking RF ≥40 pack-years 20623770
652 Multiple System Atrophy human Smoking RF ≥40 pack-years 20623770
652 Tourette Syndrome human Smoking RF maternal smoking 22738448
652 Tourette Syndrome human Smoking RF maternal smoking 20654033
652 Alzheimer's Disease human Smoking RF 23422663
652 Amyotrophic Lateral Sclerosis human Smoking RF Ever smoker(Adjustment for education) 10645818
652 Amyotrophic Lateral Sclerosis human Smoking RF Current smoker(Adjustment for education) 10645818
652 Amyotrophic Lateral Sclerosis human Smoking RF Ever smoker（Adjustment for education and alcohol consumption） 10645818
652 Amyotrophic Lateral Sclerosis human Smoking RF Current smoker（Adjustment for education and alcohol consumption） 10645818
652 Amyotrophic Lateral Sclerosis human Smoking RF Duration of smoking ≥20 years(Adjustment for education) 10645818
652 Amyotrophic Lateral Sclerosis human Smoking RF Duration of smoking ≥20 years（Adjustment for education and alcohol consumption） 10645818
652 Amyotrophic Lateral Sclerosis human Smoking RF Cumulative pack-years<20 pack-years(Adjustment for education) 10645818
652 Amyotrophic Lateral Sclerosis human Smoking RF Cumulative pack-years≥20 pack-years(Adjustment for education) 10645818
652 Amyotrophic Lateral Sclerosis human Smoking RF Cumulative pack-years<20 pack-years（Adjustment for education and alcohol consumption） 10645818
652 Amyotrophic Lateral Sclerosis human Smoking RF Cumulative pack-years≥20 pack-years（Adjustment for education and alcohol consumption） 10645818
652 Amyotrophic Lateral Sclerosis human Smoking RF Combination recency and dose：Current, <20 pack years(Adjustment for education) 10645818
652 Amyotrophic Lateral Sclerosis human Smoking RF Combination recency and dose:Current, ≥20 pack-years（Adjustment for education and alcohol consumption） 10645818
652 Amyotrophic Lateral Sclerosis human Smoking RF Combination recency and dose：Current, <20 pack years(Adjustment for education) 10645818
652 Amyotrophic Lateral Sclerosis human Smoking RF Combination recency and dose：Current, ≥20 pack-years（Adjustment for education and alcohol consumption） 10645818
652 Alzheimer’s Disease human Smoking PF 30103328
652 Alzheimer’s Disease human Smoking RF 29606955
652 Alzheimer’s Disease human Smoking RF 2754163
652 Alzheimer’s Disease human Smoking PF Light smoker 9346343
652 Alzheimer’s Disease human Smoking RF Daily smoker 9346343
652 Alzheimer's Disease human Smoking RF 26495049
652 Alzheimer's Disease human Smoking RF 24596166
652 Alzheimer's disease human Smoking PF 30792733
652 Alzheimer's disease human Smoking RF smoking more than 2 packs a day 20975015
652 Alzheimer's disease human Smoking RF in APOE e4 carriers 20847559
652 Amyotrophic lateral sclerosis human Smoking RF 31155341
652 Amyotrophic lateral sclerosis human Smoking RF 30786056
652 Amyotrophic Lateral Sclerosis human Smoking RF Former smokers （Adjusted for Age） 21320987
652 Amyotrophic Lateral Sclerosis human Smoking RF Current smokers （Adjusted for Age） 21320987
652 Amyotrophic Lateral Sclerosis human Smoking RF Ever smokers （Adjusted for Age） 21320987
652 Amyotrophic Lateral Sclerosis human Smoking RF Pack-years smoked ≤20 （Adjusted for Age） 21320987
652 Amyotrophic Lateral Sclerosis human Smoking RF Pack-years smoked 21-35 （Adjusted for Age） 21320987
652 Amyotrophic Lateral Sclerosis human Smoking RF Pack-years smoked ＞ 35 （Adjusted for Age） 21320987
652 Amyotrophic Lateral Sclerosis human Smoking RF Former smokers （Adjusted for Age, Body Mass Index, Physical Activity, and Education） 21320987
652 Amyotrophic Lateral Sclerosis human Smoking RF Ever smokers （Adjusted for Age, Body Mass Index, Physical Activity, and Education） 21320987
652 Amyotrophic Lateral Sclerosis human Smoking RF Pack-years smoked ≤20 （Adjusted for Age, Body Mass Index, Physical Activity, and Education） 21320987
652 Amyotrophic Lateral Sclerosis human Smoking RF Pack-years smoked 21-35 （Adjusted for Age, Body Mass Index, Physical Activity, and Education） 21320987
652 Amyotrophic Lateral Sclerosis human Smoking RF Pack-years smoked ＞ 35 （Adjusted for Age, Body Mass Index, Physical Activity, and Education） 21320987
652 Amyotrophic Lateral Sclerosis human Smoking RF Former smokers （Adjusted for Age） 21320987
652 Amyotrophic Lateral Sclerosis human Smoking RF Ever smokers （Adjusted for Age） 21320987
652 Amyotrophic Lateral Sclerosis human Smoking RF Pack-years smoked 21-35 （Adjusted for Age） 21320987
652 Amyotrophic Lateral Sclerosis human Smoking RF Former smokers （Adjusted for Age, Body Mass Index, Physical Activity, and Education） 21320987
652 Amyotrophic Lateral Sclerosis human Smoking RF Ever smokers （Adjusted for Age, Body Mass Index, Physical Activity, and Education） 21320987
652 Amyotrophic Lateral Sclerosis human Smoking RF Pack-years smoked 21-35 （Adjusted for Age, Body Mass Index, Physical Activity, and Education） 21320987
652 Amyotrophic Lateral Sclerosis human Smoking RF Former smokers （Adjusted for Age） 21320987
652 Amyotrophic Lateral Sclerosis human Smoking RF Ever smokers （Adjusted for Age） 21320987
652 Amyotrophic Lateral Sclerosis human Smoking RF Pack-years smoked ≤20 （Adjusted for Age） 21320987
652 Amyotrophic Lateral Sclerosis human Smoking RF Pack-years smoked ＞35（Adjusted for Age） 21320987
652 Amyotrophic Lateral Sclerosis human Smoking RF Former smokers （Adjusted for Age, Body Mass Index, Physical Activity, and Education） 21320987
652 Amyotrophic Lateral Sclerosis human Smoking RF Ever smokers （Adjusted for Age, Body Mass Index, Physical Activity, and Education） 21320987
652 Amyotrophic Lateral Sclerosis human Smoking RF Pack-years smoked ≤20 （Adjusted for Age, Body Mass Index, Physical Activity, and Education） 21320987
652 Amyotrophic Lateral Sclerosis human Smoking RF Pack-years smoked ＞35（Adjusted for Age, Body Mass Index, Physical Activity, and Education） 21320987
652 Amyotrophic Lateral Sclerosis human Smoking RF Current（Crude OR） 17923612
652 Amyotrophic Lateral Sclerosis human Smoking RF Current（Adj. OR） 17923612
652 Amyotrophic Lateral Sclerosis human Smoking RF Current smokers 19399866
652 Amyotrophic Lateral Sclerosis human Smoking RF Time spent smoking≥30years 19399866
652 Motor Neuron Disease human Smoking RF Ever smokers 22559076
652 Parkinson's Disease human Smoking PF 21059511
652 Parkinson's Disease human Smoking PF 19540050
652 Parkinson's Disease human Smoking PF 11060508
652 Parkinson's Disease human Smoking PF 19188574
652 Parkinson's Disease human Smoking PF 30772279
652 Alzheimer’s Disease human Smoking RF intrinsic epigenetic age acceleration; current smoker (N=939); former smoker, stopped within past 12 months (N=158); former smoker, stopped more than 12 months ago (N=1309); never smoker (N=2533), and not coded (N=62). 30167451
652 Amyotrophic Lateral Sclerosis human Smoking RF Bulbar cases 19922125
652 Amyotrophic Lateral Sclerosis human Smoking RF Bulbar cases 19922125
653 Parkinson's Disease human SN hyperechogenicity (SN+) RF 23115051
654 Tourette Syndrome human socio-economic status (SES) RF Low socio-economic status (SES) 24138188
655 Alzheimer’s Disease human Socioeconomic status (SIMD, SD) RF intrinsic epigenetic age acceleration 30167451
656 Alzheimer’s Disease human Solvent exposure RF Any positive response to a named solvent group 7771442
656 Alzheimer’s Disease human Solvent exposure RF Any positive response to a named solvent group. 7771442
657 Amyotrophic Lateral Sclerosis human Solvents/Chemicals RF with the total SALS group 16946624
657 Amyotrophic Lateral Sclerosis human Solvents/Chemicals RF with male patients 16946624
657 Amyotrophic Lateral Sclerosis human Solvents/Chemicals RF with female patients 16946624
658 Alzheimer's disease human soy food products RF 24440006
659 Amyotrophic Lateral Sclerosis human spatial locations RF 18573277
660 Amyotrophic lateral sclerosis human Sport activity PF 24706338
661 Alzheimer's disease human statin use PF 20533968
662 Alzheimer's Disease human stress RF chronic stress 20044001
663 Alzheimer's disease human stroke RF previous stroke history 24489845
663 Alzheimer's disease human stroke RF mediated the association between selected CV risk factors and LOAD 27533593
663 Alzheimer's disease human stroke RF mediated the association between selected CV risk factors and LOAD 27533593
663 Amyotrophic lateral sclerosis human Stroke RF all 26260352
663 Amyotrophic lateral sclerosis human Stroke RF Haemorrhagic 26260352
663 Amyotrophic lateral sclerosis human Stroke RF Ischaemic 26260352
663 Amyotrophic lateral sclerosis human Stroke RF Unspecified 26260352
663 Parkinson's Disease human stroke RF 26576320
663 Parkinson's Disease human stroke RF 9778597
664 Alzheimer’s Disease human Stroke/transient ischemic attack RF after Hemodialysis Initiation 30093374
665 Creutzfeldt-Jakob disease human Surgery RF undergo surgery 18257690
665 Creutzfeldt-Jakob disease human Surgery PF undergo surgery 18257690
665 Creutzfeldt-Jakob disease human Surgery PF undergo surgery;used proxy informants to acquire information about case subjects and control subjects (consistent ascertainment) 18257690
665 Creutzfeldt-Jakob disease human Surgery RF undergo surgery;proxy informants acted only on behalf of case subjects (inconsistent data ascertainment) 18257690
665 Creutzfeldt-Jakob disease human Surgery RF 10073510
665 Creutzfeldt-Jakob disease human Surgery PF Surgery at any time 3066847
665 Creutzfeldt-Jakob disease human Surgery RF Any surgery 12196646
665 Creutzfeldt-Jakob disease human Surgery PF Tonsillectomy 12196646
665 Creutzfeldt-Jakob disease human Surgery PF Appendectomy 12196646
665 Creutzfeldt-Jakob disease human Surgery RF Gynecologic 12196646
665 Creutzfeldt-Jakob disease human Surgery RF 18843192
665 Creutzfeldt-Jakob disease human Surgery RF predating clinical onset by 1 or more years 18843192
665 Creutzfeldt-Jakob disease human Surgery RF at a 1- to 9-year time lag 18843192
665 Creutzfeldt-Jakob disease human Surgery RF ophthalmological surgery (> 1980) 19144172
665 Creutzfeldt-Jakob disease human Surgery RF orthopaedic surgery 19144172
665 Creutzfeldt-Jakob disease human Surgery RF orthopaedic surgery (> 1980) 19144172
666 Parkinson's Disease human tea drinking RF 11060508
667 Tuberous sclerosis complex human The presence of seizures RF 21449900
668 Amyotrophic lateral sclerosis human The widespread distribution of dioxins, PCBs and PAHs RF 28476168
669 Tourette Syndrome human third-degree relatives RF 26083307
670 Amyotrophic lateral sclerosis human Thyroid PF 27065942
671 Amyotrophic lateral sclerosis human toenail mercury levels RF 29314106
672 Parkinson's Disease human Total daily physical activity PF Older adults 31046115
673 Alzheimer’s Disease human Total:HDL cholesterol (ratio) RF extrinsic epigenetic age acceleration 30167451
674 Amyotrophic Lateral Sclerosis human Toxin exposure RF 16963407
675 Parkinson's Disease human Toxins other than pesticide RF 21059511
676 Amyotrophic lateral sclerosis human Trauma RF Previous trauma 29681882
676 Amyotrophic lateral sclerosis human Trauma RF 25059395
676 Amyotrophic Lateral Sclerosis human Trauma RF At least one traumatic event(All traumatic event) 22537412
676 Amyotrophic Lateral Sclerosis human Trauma RF Number of events reported:1(All traumatic event) 22537412
676 Amyotrophic Lateral Sclerosis human Trauma RF Number of events reported:3+(All traumatic event) 22537412
676 Amyotrophic Lateral Sclerosis human Trauma RF Worst traumatic event reported:Moderate(All traumatic event) 22537412
676 Amyotrophic Lateral Sclerosis human Trauma RF Worst traumatic event reported:Severe(All traumatic event) 22537412
676 Amyotrophic Lateral Sclerosis human Trauma RF Number of events requiring hospitalization:1(All traumatic event) 22537412
676 Amyotrophic Lateral Sclerosis human Trauma RF Number of events leading to disability:1(All traumatic event) 22537412
676 Amyotrophic Lateral Sclerosis human Trauma RF At least one traumatic event（Old traumatic events） 22537412
676 Amyotrophic Lateral Sclerosis human Trauma RF Number of events reported：2（Old traumatic events） 22537412
676 Amyotrophic Lateral Sclerosis human Trauma RF Number of events reported：:3+（Old traumatic events） 22537412
676 Amyotrophic Lateral Sclerosis human Trauma RF Worst traumatic event reported：Moderate（Old traumatic events） 22537412
676 Amyotrophic Lateral Sclerosis human Trauma RF Worst traumatic event reported：Severe（Old traumatic events） 22537412
676 Amyotrophic Lateral Sclerosis human Trauma RF Number of events requiring hospitalization：2+（Old traumatic events） 22537412
676 Amyotrophic Lateral Sclerosis human Trauma RF Number of events leading to disability：2+（Old traumatic events） 22537412
677 Amyotrophic lateral sclerosis human Trauma leading to disability RF 29063790
677 Amyotrophic lateral sclerosis human Trauma leading to disability RF 29063790
677 Amyotrophic lateral sclerosis human Trauma leading to disability RF 1 Trauma 29063790
677 Amyotrophic lateral sclerosis human Trauma leading to disability RF 1 Trauma 29063790
677 Amyotrophic lateral sclerosis human Trauma leading to disability RF 2+ Trauma 29063790
677 Amyotrophic lateral sclerosis human Trauma leading to disability RF 2+ Trauma 29063790
678 Frontotemporal Dementia human traumatic brain injury (TBI) RF 28946566
678 Frontotemporal Dementia human traumatic brain injury (TBI) RF 25982564
678 Alzheimer's Disease human Traumatic brain injury (TBI) RF 26401777
678 Frontotemporal Dementia human traumatic brain injury (TBI) RF 22465176
678 Frontotemporal Lobar Degeneration human traumatic brain injury (TBI) RF 22465176
678 Frontotemporal Lobar Degeneration human traumatic brain injury (TBI) RF Remote TBI with extended loss of consciousness (TBI-ext) 25531628
678 Chronic Traumatic Encephalopathy mice Traumatic brain injury (TBI) RF through the induction of tau hyperphosphorylation and aggregation 31317824
678 Parkinson's Disease human Traumatic brain injury (TBI) RF 23150532
679 Alzheimer's Disease human traumatic brain injury (TBI) with reported loss of consciousness (LOC) RF 29389151
680 Alzheimer's Disease human treadmill exercise PF 25960981
681 Parkinson's Disease human Trichloroethylene RF 18157908
682 Parkinson's Disease human type 1 Gaucher disease RF 20177787
683 Parkinson's Disease human Type 2 diabetes RF 17251276
683 Parkinson's Disease human Type 2 diabetes RF 17251276
684 Alzheimer's disease human type 2 diabetes mellitus (T2DM) RF a risk factor for MCI progressing into AD 27729793
685 Amyotrophic Lateral Sclerosis human Type of Herbicide/Pesticide Exposure RF Industrial exposure to herbicides/pesticides 16946624
685 Amyotrophic Lateral Sclerosis human Type of Herbicide/Pesticide Exposure RF Industrial exposure to herbicides/pesticides 16946624
685 Amyotrophic Lateral Sclerosis human Type of Herbicide/Pesticide Exposure RF industrial exposure being occasional 16946624
685 Amyotrophic Lateral Sclerosis human Type of Herbicide/Pesticide Exposure RF industrial exposure being occasional 16946624
685 Amyotrophic Lateral Sclerosis human Type of Herbicide/Pesticide Exposure RF industrial exposure being regular 16946624
685 Amyotrophic Lateral Sclerosis human Type of Herbicide/Pesticide Exposure RF industrial exposure being regular 16946624
685 Amyotrophic Lateral Sclerosis human Type of Herbicide/Pesticide Exposure RF Exposure to herbicides/pesticides through regular gardening 16946624
685 Amyotrophic Lateral Sclerosis human Type of Herbicide/Pesticide Exposure RF Exposure to herbicides/pesticides through regular gardening 16946624
686 Tourette Syndrome human type of home education RF 22738448
687 Alzheimer's Disease human underweight RF at age 30, 40, or 45 years 18835864
688 Alzheimer's disease human urbanization status RF 24489845
689 Parkinson's Disease human Uric Acid PF 24955210
690 Amyotrophic lateral sclerosis human Use of chemicals in job or hobby RF residents of New England or the bordering New York region at the time of enrollment 28122372
690 Amyotrophic lateral sclerosis human Use of chemicals in job or hobby RF residents of New England or the bordering New York region at the time of enrollment 28122372
691 progressive supranuclear palsy human Use of firearm in service RF 29973911
692 Amyotrophic lateral sclerosis human Use of statins PF 25059395
693 Amyotrophic lateral sclerosis human Using fertilizer to treat gardens RF Exposure in the period from 30 years ago to 10 years ago 24979055
694 Alzheimer's Disease human vascular risk RF 20164563
695 Alzheimer's disease human vascular risk factors(hypertension, diabetes, cerebrovascular diseases, and hypercholesterolemia) RF people with mild cognitive impairment (MCI) 21490316
696 Parkinson's Disease human Vitamin D and Vitamin E PF 24955210
697 Alzheimer's disease human vitamin D insufficiency RF 22306846
698 Alzheimer's disease mice Vulnerability to stress RF pharmacological treatment with venlafaxine may represent a therapeutic strategy for the treatment of stress-related disorders, including AD 21797840
699 Alzheimer’s Disease human Wandering RF exhibit wandering in the middle or late stages 8422268
700 Amyotrophic lateral sclerosis human Water-Ski RF residents of New England or the bordering New York region at the time of enrollment 28122372
701 Alzheimer's Disease human weight gain RF between 30 and 50 years for any 5-year interval 18835864
702 Parkinson's Disease human welding RF 11148228
451 Parkinson's Disease human well water ingestion RF 18464276
451 Parkinson's Disease human well water ingestion RF 12140099
451 Parkinson's Disease human well water ingestion RF 11437458
451 Parkinson's Disease human well water ingestion RF 9778597
703 Amyotrophic lateral sclerosis human Work PF 24706338
703 Amyotrophic lateral sclerosis human Work PF Significant adjusted OR 24706338
704 Amyotrophic lateral sclerosis human Work & Sport PF 24706338
704 Amyotrophic lateral sclerosis human Work & Sport PF Significant adjusted OR 24706338
705 Alzheimer’s Disease human Years of education PF 30103328
706 Alzheimer’s Disease human Yemenite origin RF 30103328
707 Creutzfeldt-Jakob disease human Zoster RF Zoster in adult life 3066847
708 Alzheimer's Disease human β- hexachlorocyclohexane RF 22904031
526 Alzheimer’s Disease human Insulin resistance (IR) RF 30112972
422 Alzheimer's disease human Dyslipidemia RF 31771063
422 Alzheimer's disease human Dyslipidemia RF (a higher LDL cholesterol level) 32903761
931 Alzheimer's disease human Multiple vascular risk factors (VRFs) RF especially in APOE ε4 carriers 31587263
932 Alzheimer's disease human Depressive symptoms RF for pre-frailty and frailty in patients with AD 32335425
400 Alzheimer's disease human depression RF 33126696
933 Alzheimer's disease human diabetes mellitus RF 33126696
934 Alzheimer's disease human older age RF 33126696
935 Alzheimer's disease human treated dyslipidemia PF 33126696
936 Alzheimer's disease human Male sex RF 32043803
400 Alzheimer's disease human Depression RF 32043803
937 Alzheimer's disease human polypharmacy RF 32251456
938 Alzheimer's disease human inappropriate use anti-dementia drugs RF 32251456
939 Alzheimer's disease human irregular medication use anti-dementia drugs RF 32251456
940 Alzheimer's disease human number of functional tooth units (FTU) RF 32116259
941 Alzheimer's disease human Statin therapy PF 32753051
942 Alzheimer's disease human coronavirus disease 2019 (COVID-19) RF 32715280
943 Alzheimer's disease human age at baseline RF 32485802
944 Alzheimer's disease human daytime napping PF 33150399
425 Alzheimer's disease human education PF higher education;more likely to consume colorful fruits and vegetables 32970519
945 Alzheimer's disease human Severe periodontitis with tooth loss RF 33124208
946 Alzheimer's disease human increasing years of schooling PF 33177243
947 Alzheimer's disease human pulse pressure (PP) RF 32960784
400 Alzheimer's disease human Depression RF 32003417
948 Alzheimer's disease human severe hypoglycaemia RF 32870568
401 Alzheimer's disease human Diabetes RF 32767997
480 Alzheimer's disease human Heart disease RF 32767997
663 Alzheimer's disease human Stroke RF 32767997
949 Alzheimer's disease human Delirium RF 32767997
950 Alzheimer's disease human moderate depression RF healthy-to-MCI/dementia 33088897
506 Alzheimer's disease human hypertension PF MCI-to-dementia 33088897
951 Amyotrophic lateral sclerosis human lead exposure RF environmental/occupational 31578652
333 Amyotrophic lateral sclerosis human alcohol consumption RF 32196748
952 Amyotrophic lateral sclerosis human head trauma RF 32019087
953 Amyotrophic lateral sclerosis human electric shock RF 32019087
954 Amyotrophic lateral sclerosis human use of private wells for drinking water RF 32019087
955 Amyotrophic lateral sclerosis human use of herbicides during gardening RF 32019087
956 Amyotrophic lateral sclerosis human overall fish consumption PF 32019087
957 Amyotrophic lateral sclerosis human history of occupation in the agricultural sector RF 32331298
957 Amyotrophic lateral sclerosis human history of occupation in the agricultural sector RF 32331298
958 Amyotrophic lateral sclerosis human occupational exposure to Solvents(thinners) RF 32331298
959 Amyotrophic lateral sclerosis human occupational exposure to Solvents(paint removers) RF 32331298
960 Amyotrophic lateral sclerosis human occupational exposure to electromagnetic fields RF 32331298
961 Amyotrophic lateral sclerosis human environmental exposure to electromagnetic fields RF 32331298
962 Amyotrophic lateral sclerosis human exposure to pesticides RF Occupational but not environmental exposure,particularly fungicides 32331298
439 Amyotrophic lateral sclerosis human exposure to metals RF particularly mercur yand selenium 32331298
438 Amyotrophic lateral sclerosis human Exposure to Lead RF 32331298
963 Amyotrophic lateral sclerosis human antidiabetics PF 32097525
692 Amyotrophic lateral sclerosis human Use of statins RF 32097525
429 Amyotrophic lateral sclerosis human environmental exposure to cadmium RF 33068316
429 Amyotrophic lateral sclerosis human environmental exposure to cadmium RF 33068316
438 Amyotrophic lateral sclerosis human Exposure to Lead RF 33068316
438 Amyotrophic lateral sclerosis human Exposure to Lead RF 33068316
964 Amyotrophic lateral sclerosis human Zinc PF 33068316
964 Amyotrophic lateral sclerosis human Zinc PF 33068316
663 Amyotrophic lateral sclerosis human stroke RF 32266542
965 Amyotrophic lateral sclerosis human lower BMI RF 32266542
966 Amyotrophic lateral sclerosis human regular physical activity RF 32266542
967 Amyotrophic lateral sclerosis human gut microbiota RF/PF butyrate-producing bacteria are less abundant in the gastrointestinal tracts of people with ALS (PALS) 33135936
676 Amyotrophic lateral sclerosis human trauma RF 33130429
968 Amyotrophic lateral sclerosis human solvents RF 33130429
969 Amyotrophic lateral sclerosis human diesel/CVD interaction RF 33130429
970 Amyotrophic lateral sclerosis human trauma/solvents interaction PF 33130429
968 Amyotrophic lateral sclerosis human solvents RF 33130429
676 Amyotrophic lateral sclerosis human trauma RF 33130429
438 Amyotrophic lateral sclerosis human Exposure to Lead RF 33130429
971 Amyotrophic lateral sclerosis human CVD RF 33130429
972 Amyotrophic lateral sclerosis human lead/solvents interaction PF 33130429
973 Amyotrophic lateral sclerosis human Vitamin A RF higher serum Vitamin A 32625160
974 Amyotrophic lateral sclerosis human Vitamin B2 PF higher serum Vitamin B2 32625160
975 Amyotrophic lateral sclerosis human Vitamin B9 PF higher serum Vitamin B9 32625160
277 Amyotrophic lateral sclerosis human Vitamin C PF higher serum Vitamin C 32625160
976 Amyotrophic lateral sclerosis human Exposure to extremely low frequency magnetic fields (ELF-MF) RF 32946420
952 Amyotrophic lateral sclerosis human Head trauma RF with significantly greater effects for injuries occurring 10 or more years prior to symptom onset 33006184
977 Amyotrophic lateral sclerosis human severe electrical burns RF 33006184
978 Amyotrophic lateral sclerosis human Hobbies involving lead RF Exposures to lead 20 or more years prior to diagnosis had larger effect sizes compared to those occurring more recently. 33006184
979 Amyotrophic lateral sclerosis human Physicians RF 32687038
980 Frontotemporal dementia human exposure to Aluminum RF 33138082
981 Frontotemporal dementia human pesticides RF Insecticides,Herbicides,Fungicides 33138082
982 Frontotemporal dementia human Overall solvents and dyes RF 33138082
952 Frontotemporal dementia human Head trauma RF 33138082
983 Frontotemporal dementia human Playing sports PF 33138082
984 Frontotemporal dementia human football RF 33138082
985 Frontotemporal dementia human cycling RF 33138082
986 Frontotemporal dementia human Use of dietary supplements containing selenium RF 33138082
987 Frontotemporal dementia human Excluding specific neuroprotective supplements RF after onset of disease 33138082
652 Frontotemporal dementia human smoking RF Ever smoking 33138082
652 Frontotemporal dementia human smoking RF Passive smoking exposure 33138082
988 Lewy body dementia human positive family history of dementia or PD RF 31771063
989 Lewy body dementia human vascular cognitive impairment (VCI) RF in tremor group and non-tremor group 32903761
400 Lewy body dementia human Depression RF 32043803
990 Multiple System Atrophy human use of non-aspirin nonsteroidal anti-inflammatory drugs (NSAIDs) PF 31661696
990 Multiple System Atrophy human use of non-aspirin nonsteroidal anti-inflammatory drugs (NSAIDs) PF Cumulative doses were used to divide observations into tertiles creating 3 groups of equal size (T1–3) based on the consumption in defined daily dose(DDD) with T1 representing the group with the lowest use and T3 the highest. 31661696
990 Multiple System Atrophy human use of non-aspirin nonsteroidal anti-inflammatory drugs (NSAIDs) PF Cumulative doses were used to divide observations into tertiles creating 3 groups of equal size (T1–3) based on the consumption in DDDs with T1 representing the group with the lowest use and T3 the highest. 31661696
991 Parkinson's Disease human well water(containing heavy metals and nitrates) RF Consumption of well water containing heavy metals and nitrates in early life 32351250
992 Parkinson's Disease human Vascular Inflammation:blood-brain barrier(BBB) RF 32733633
993 Parkinson's Disease human Education? PF 32865628
506 Parkinson's Disease human Hypertension RF 32865628
388 Parkinson's Disease human coffee consumption PF 32943485
652 Parkinson's Disease human smoking PF 32943485
604 Parkinson's Disease human physical activity PF 32943485
994 Parkinson's Disease human family history of PD RF 32943485
995 Parkinson's Disease human dyspepsia RF 32943485
962 Parkinson's Disease human exposure to pesticides RF 32943485
996 Parkinson's Disease human oils RF 32943485
997 Parkinson's Disease human metals RF 32943485
998 Parkinson's Disease human general anesthesia RF 32943485
logo
All rights reserved: Institutes for Systems Genetics, West China Hospital